UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.32B |
| 2 |
Elevance Health
ELV
|
+$282M |
| 3 |
Warner Bros
WBD
|
+$173M |
| 4 |
Visa
V
|
+$167M |
| 5 |
AbbVie
ABBV
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Automatic Data Processing
ADP
|
+$490M |
| 2 |
Amazon
AMZN
|
+$350M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Baidu
BIDU
|
+$219M |
| 5 |
TC Energy
TRP
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.54% |
| 2 | Healthcare | 15.22% |
| 3 | Financials | 12.07% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Communication Services | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Interface
TILE
$2.22B
| $655K | ﹤0.01% |
52,219
-3,034
| -5% | -$40.2K |
|
2177
Mesa Laboratories
MLAB
$574M
| $654K | ﹤0.01% |
3,209
| – | – |
|
|
AMWD
2178
DELISTED
American Woodmark
AMWD
| $653K | ﹤0.01% |
14,498
+112
| +0.8% | +$5.41K |
|
2179
Sprinklr
CXM
$1.61B
| $650K | ﹤0.01% |
64,302
-20,812
| -24% | -$253K |
|
|
HNGR
2180
DELISTED
Hanger Inc.
HNGR
| $649K | ﹤0.01% |
45,349
+453
| +1% | +$7.35K |
|
|
AGEN
2181
Agenus
AGEN
$290M
| $649K | ﹤0.01% |
17,046
+8,215
| +93% | +$298K |
|
2182
Flywire
FLYW
$2.16B
| $647K | ﹤0.01% |
+36,690
| New | +$852K |
|
2183
Liberty Latin America Class A
LILA
$1.67B
| $645K | ﹤0.01% |
121,733
| – | – |
|
|
FARO
2184
DELISTED
Faro Technologies
FARO
| $644K | ﹤0.01% |
20,880
-764
| -4% | -$28K |
|
2185
Bally's
BALY
$658M
| $643K | ﹤0.01% |
32,501
| – | – |
|
2186
Compass
COMP
$9.66B
| $643K | ﹤0.01% |
+178,061
| New | +$974K |
|
2187
Amplitude
AMPL
$1.41B
| $643K | ﹤0.01% |
+44,974
| New | +$789K |
|
|
RDUS
2188
DELISTED
Radius Health, Inc.
RDUS
| $642K | ﹤0.01% |
61,913
-215
| -0.3% | -$1.6K |
|
2189
NETGEAR
NTGR
$635M
| $641K | ﹤0.01% |
34,637
| – | – |
|
2190
Magnachip Semiconductor
MX
$145M
| $641K | ﹤0.01% |
44,123
+16,645
| +61% | +$286K |
|
|
OSG
2191
Octave Specialty Group
OSG
$222M
| $640K | ﹤0.01% |
56,423
+9,354
| +20% | +$88.8K |
|
2192
Mativ Holdings
MATV
$711M
| $640K | ﹤0.01% |
25,481
+3,123
| +14% | +$82.5K |
|
2193
Titan International
TWI
$475M
| $640K | ﹤0.01% |
+42,354
| New | +$684K |
|
2194
Arcutis Biotherapeutics
ARQT
$3.18B
| $639K | ﹤0.01% |
29,972
| – | – |
|
2195
Hackett Group
HCKT
$287M
| $638K | ﹤0.01% |
33,641
+1,079
| +3% | +$23.2K |
|
|
AAN
2196
DELISTED
The Aaron's Company Inc
AAN
| $638K | ﹤0.01% |
43,856
+1,759
| +4% | +$33.6K |
|
2197
HCI Group
HCI
$2.41B
| $637K | ﹤0.01% |
9,400
-1,626
| -15% | -$107K |
|
|
GOLD
2198
Gold.com Inc
GOLD
$1.26B
| $637K | ﹤0.01% |
19,742
+4,262
| +28% | +$153K |
|
2199
Atara Biotherapeutics
ATRA
$76.1M
| $635K | ﹤0.01% |
3,261
| – | – |
|
|
MGI
2200
DELISTED
MoneyGram International, Inc. New
MGI
| $635K | ﹤0.01% |
63,474
-37,478
| -37% | -$377K |
|
Similar funds
UBS AM's Q2 2022 Portfolio in Review
As of Q2 2022, UBS AM held 2,854 positions worth $191B, down 18% from $233B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q2 2022 filing shows 130 new, 1,168 increased, 1,130 reduced and 164 closed positions. Its largest new stake was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M. The largest sale was Automatic Data Processing, an estimated $490M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q2 2022 buy was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M.
- UBS AM added most to Apple in Q2 2022, an estimated $1.32B increase.
- UBS AM's biggest Q2 2022 reduction was Automatic Data Processing, cutting an estimated $490M.
- UBS AM fully exited TC Energy in Q2 2022, selling an estimated $214M.
- UBS AM's ten largest holdings make up 22% of its $191B portfolio in Q2 2022.
- UBS AM opened 130 new positions and closed 164 in Q2 2022.
- UBS AM's portfolio value fell 18% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.